The Impact of Xanomeline and Trospium Chloride on Cognitive Impairment in Acute Schizophrenia: Replication in Pooled Data From Two Phase 3 Trials.

已完结 10 由小波发布于 2025/1/8 10:44:47

DOI:10.1176/appi.ajp.20240076
作者：William P Horan,?Colin Sauder,?Philip D Harvey,?Ian S Ramsay,?Samantha E Yohn,?Richard S E Keefe,?Vicki G Davis,?Steven M Paul,?Stephen K Brannan
文献类型：期刊论文
补充材料：只需要正文

American Psychiatric Association Publishing

Abstract：Objective: Xanomeline and trospium chloride (formerly known as KarXT), a novel M1/M4 muscarinic receptor agonist, demonstrated efficacy across phase 2 and 3 trials as monotherapy for the tre

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierWater collection through a directional leaf vein pattern by fast laser marker ablation of stainless-steel